Pseudotyped adeno‐associated viral vector tropism and transduction efficiencies in murine wound healing

Abstract Cell specific gene transfer and sustained transgene expression are goals of cutaneous gene therapy for tissue repair and regeneration. Adeno‐associated virus serotype 2 ( AAV 2/2) mediated gene transfer to the skin results in stable transgene expression in the muscle fascicles of the panniculus carnosus in mice, with minimal gene transfer to the dermal or epidermal elements. We hypothesized that pseudotyped AAV vectors may have a unique and characteristic tropism and transduction efficiency profile for specific cells in the cutaneous wounds. We compared transduction efficiencies of cells in the epidermis, cells in the dermis, and the fascicles of the panniculus carnosus by AAV 2/2 and three pseudotyped AAV vectors, AAV 2/5, AAV 2/7, and AAV 2/8 in a murine excisional wound model. AAV 2/5 and AAV 2/8 result in significantly enhanced transduction of cells both in the epidermis and the dermis compared to AAV 2/2. AAV 2/5 transduces both the basilar and supra‐basilar keratinocytes. In contrast, AAV 2/8 transduces mainly supra‐basilar keratinocytes. Both AAV 2/7 and AAV 2/8 result in more efficient gene transfer to the muscular panniculus carnosus compared to AAV 2/2. The capsid of the different pseudotyped AAV vectors produces distinct tropism and efficiency profiles in the murine wound healing model. Both AAV 2/5 and AAV 2/8 administration result in significantly enhanced gene transfer. To further characterize cell specific transduction and tropism profiles of the AAV pseudotyped vectors, we performed in vitro experiments using human and mouse primary dermal fibroblasts. Our data demonstrate that pseudotyping strategy confers a differential transduction of dermal fibroblasts, with higher transduction of both human and murine cells by AAV 2/5 and AAV 2/8 at early and later time points. At later time points, AAV 2/2 demonstrates increased transduction. Interestingly, AAV 2/8 appears to be more efficacious in transducing human cells as compared to AAV 2/5. The pseudotype‐specific pattern of transduction and tropism observed both in vivo and in vitro suggests that choice of AAV vectors should be based on the desired target cell and the timing of transgene expression in wound healing for gene transfer therapy in dermal wounds.